1126619-17-7
1126619-17-7
Chemical Structure
Tipranavir-d5
Synonym(s): PNU-140690-d5
- CAS No.: 1126619-17-7
- Formula:C31H28D5F3N2O5S
- Molecular Weight:607.70
InChIKey: SUJUHGSWHZTSEU-LFWCKQPTSA-N
SMILES: O=S(C1=NC=C(C(F)(F)F)C=C1)(NC2=CC=CC([C@H](C3=C(O)C[C@@](CCC)(CCC4=C([2H])C([2H])=C([2H])C([2H])=C4[2H])OC3=O)CC)=C2)=O
Biological Activity: Tipranavir-d5 (PNU-140690-d5) is the deuterium labeled Tipranavir (HY-15148). Tipranavir (PNU-140690) inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-protease inhibitor (PI)-resistant HIV-1 isolates with IC50s of 66-410 nM[1][2]. Tipranavir inhibits SARS-CoV-2 3CLpro activity[3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Tipranavir-d5 | Tipranavir-d5 (PNU-140690-d5) is the deuterium labeled Tipranavir (HY-15148). Tipranavir (PNU-140690) inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-protease inhibitor (PI)-resistant HIV-1 isolates with IC50s of 66-410 nM. Tipranavir inhibits SARS-CoV-2 3CLpro activity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Tipranavir (Standard) | ≥98% | Tipranavir (Standard) is the analytical standard of Tipranavir. This product is intended for research and analytical applications. Tipranavir (PNU-140690) inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-protease inhibitor (PI)-resistant HIV-1 isolates with IC50s of 66-410 nM. Tipranavir inhibits SARS-CoV-2 3CLpro activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Tipranavir-d7 | 98.94% | Tipranavir-d7 is deuterated labeled Tipranavir (HY-15148). Tipranavir (PNU-140690) inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-protease inhibitor (PI)-resistant HIV-1 isolates with IC50s of 66-410 nM. Tipranavir inhibits SARS-CoV-2 3CLpro activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Tipranavir | 98.0% | Tipranavir (PNU-140690) inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-protease inhibitor (PI)-resistant HIV-1 isolates with IC50s of 66-410 nM. Tipranavir inhibits SARS-CoV-2 3CLpro activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
